// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Severe Hypoglycemia Rates Are Highest among those with Suboptimal Reporting Behaviour—Results from the InHypo-DM Study

ALEXANDRIA RATZKI-LEEWING - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Flash Glucose Monitoring Reflects Graft Function after Clinical Islet Transplantation—An Initial Report

ANNA LAM - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Frequency, Severity, and Associations of Gastrointestinal Symptoms in Adults and Children with Type 1 Diabetes

FARID H. MAHMUD - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Randomized Trial of a Tailored Cognitive Behavioral Intervention in Type 2 Diabetes with Comorbid Depressive and/or Distress Symptoms—Twelve-Month Outcomes from COMRADE

DOYLE M. CUMMINGS - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Variability and Reproducibility in the Rise in Blood Glucose Levels in Response to High Intensity Interval Training (HIIT) in Type 1 Diabetes (T1D)—The FIT Reproducibility Study

MICHAEL RIDDELL - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Insulin glargine

Burden of Hospitalization in Young-Onset Type 2 Diabetes—The Hong Kong Diabetes Register

CALVIN KE - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and Metabolic Syndrome

MARTIN LEDUC - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Somatostatin Receptor II Antagonism Improves Glucagon Counterregulatory Responses to Recurrent Hypoglycemia in Male Sprague-Dawley Rats

MICHAEL RIDDELL - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Somatostatin

Key Factors for Overcoming Psychological Insulin Resistance—An Examination of a Large International Sample through Content Analysis

HEATHER L. STUCKEY - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Beneficial Effects of Tamoxifen Treatment in Type 1 Diabetes

JUAN ZHENG - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Tamoxifen

Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) and Diabetes—Prespecified Analyses of ODYSSEY OUTCOMES

KAUSIK K. RAY - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Atorvastatin

Implementation of Person-Centered Methods in Group-Based Diabetes Education

VIBEKE STENOV - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Neighborhood Walkability and Diabetes-Related Complications

REEMA SHAH - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Plasma Uric Acid (PUA), Renal Hemodynamic Function, and Arterial Stiffness at the Extremes of T1D Duration-Adolescents vs. Adults with T1D for =50 Years

YULIYA LYTVYN - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Angiotensin II

Suppression of STAT3 Signaling Promotes Acinar-to-ß Reprogramming Induced by Distinct Transcription Factors

MASAKI MIURA - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ex Vivo Bloodless Oxygen Carrier for Perfusion of DCD Kidneys during Subnormothermic Storage

P. Luke - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Ex Vivo-Expanded Human CD19+CD73–CD25+CD71+TIM-1+ B Regulatory Cells Can Prolong Allograft Survival in a Humanized Mouse Model of Skin Transplantation and Are Dependent on TIM-1-Mediated Regulation of STAT3 Signaling

S. Shankar - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

In Vivo and In Vitro PPAR-y Activation Decreases M1-Macrophage Polarization and Improves Liver Ischemia Reperfusion Injury

I. Linares - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Rosiglitazone maleate

Mycoplasma hominis Infection in Lung Transplant Recipients: A Retrospective Case Series

J. Wright - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Medical Decision Analysis for the Use of Donation after Cardiac Death Donors for Simultaneous Liver-Kidney Transplant

A. Miller - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved